Every year, a handful of stocks double over the course of the year. This was even true last year, despite the market having its worst year since the Great Recession, as stocks like Tandem Diabetes (NASDAQ: TNDM), Turtle Beach (NASDAQ: HEAR), Twilio (NASDAQ: TWLO), and Crocs (NASDAQ: CROX) all delivered triple-digit returns. For this year, I’ve got my eye on two stocks […]
Read MoreAntares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; and Sumatriptan Injection USP for the acute […]
Read MoreWe’re heading into earnings season after a particularly difficult fourth quarter that saw the S&P 500 briefly cross into bear market territory on Christmas Eve. Since then, the index has rebounded. However, there’s still quite a bit of ground to make up. In a report from Goldman Sachs, U.S. chief equity strategist David Kostin said […]
Read More